JP2002523471A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523471A5
JP2002523471A5 JP2000567237A JP2000567237A JP2002523471A5 JP 2002523471 A5 JP2002523471 A5 JP 2002523471A5 JP 2000567237 A JP2000567237 A JP 2000567237A JP 2000567237 A JP2000567237 A JP 2000567237A JP 2002523471 A5 JP2002523471 A5 JP 2002523471A5
Authority
JP
Japan
Prior art keywords
antigen
vaccine
microparticles
nanoparticles
biodegradable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567237A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002523471A (ja
JP4526708B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IE1999/000087 external-priority patent/WO2000012125A1/en
Publication of JP2002523471A publication Critical patent/JP2002523471A/ja
Publication of JP2002523471A5 publication Critical patent/JP2002523471A5/ja
Application granted granted Critical
Publication of JP4526708B2 publication Critical patent/JP4526708B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000567237A 1998-09-01 1999-08-31 細胞を媒介した免疫応答を誘導する方法及びそのための非経口ワクチン製剤 Expired - Fee Related JP4526708B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9876098P 1998-09-01 1998-09-01
US60/098,760 1998-09-01
PCT/IE1999/000087 WO2000012125A1 (en) 1998-09-01 1999-08-31 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor

Publications (3)

Publication Number Publication Date
JP2002523471A JP2002523471A (ja) 2002-07-30
JP2002523471A5 true JP2002523471A5 (cg-RX-API-DMAC7.html) 2006-11-02
JP4526708B2 JP4526708B2 (ja) 2010-08-18

Family

ID=22270768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000567237A Expired - Fee Related JP4526708B2 (ja) 1998-09-01 1999-08-31 細胞を媒介した免疫応答を誘導する方法及びそのための非経口ワクチン製剤

Country Status (7)

Country Link
EP (1) EP1107783B1 (cg-RX-API-DMAC7.html)
JP (1) JP4526708B2 (cg-RX-API-DMAC7.html)
AT (1) ATE322285T1 (cg-RX-API-DMAC7.html)
AU (1) AU5441299A (cg-RX-API-DMAC7.html)
CA (2) CA2341358C (cg-RX-API-DMAC7.html)
DE (1) DE69930753D1 (cg-RX-API-DMAC7.html)
WO (1) WO2000012125A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2156718A1 (en) 1993-12-23 1995-06-29 Bruno Gander Immunological response potentiation process
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
JP4851067B2 (ja) * 2004-01-28 2012-01-11 ホソカワミクロン株式会社 ナノ粒子含有組成物およびその製造方法
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN105664147A (zh) * 2007-02-07 2016-06-15 日本电气株式会社 用于癌症的治疗剂
EP2139513B1 (en) * 2007-03-28 2012-09-05 National Institute of Immunology Polymer particles based vaccine
CA2957966C (en) * 2014-08-14 2021-11-30 Brown University Compositions for stabilizing and delivering proteins
AU2015342968B2 (en) * 2014-11-05 2021-05-27 Selecta Biosciences, Inc. Methods and compositions related to the use of low HLB surfactants in the production of synthetic nanocarriers comprising a rapalog
GB201918963D0 (en) 2019-12-20 2020-02-05 Provost Fellows Scholars And Other Members Of Board Of Trinity College Dublin Polymeric nanoparticles as vaccine adjuvants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
ATE252894T1 (de) * 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
GB9713156D0 (en) * 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines

Similar Documents

Publication Publication Date Title
JP2002523470A5 (cg-RX-API-DMAC7.html)
CA2709712C (en) Process for preparing microparticles having a low residual solvent volume
JPH11509223A5 (cg-RX-API-DMAC7.html)
US4357259A (en) Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
DE69507339D1 (de) Polymer-mikrokugeln und verfahren zu deren herstellung
CA2266629A1 (en) Taste-masked microcapsule compositions and methods of manufacture
CA2055594A1 (en) Percutaneous lymphography
JP2004502720A5 (cg-RX-API-DMAC7.html)
CA2366216A1 (en) Polycationic carbohydrates as immunostimulants in vaccines
EP1365731A1 (en) A controlled delivery system for hair care products
WO2001049272A3 (en) Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
EP1690530A3 (en) Sustained release pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
ATE234077T1 (de) Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung
CA2324403A1 (en) Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
CA2341358A1 (en) Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
DE69941848D1 (de) Orale impfstoff-zusammensetzung
JP2014523446A (ja) ポリアクリレートを基にした活性化合物含有粒子
CA2514446A1 (en) Composition comprising a mixture of active principles, and method of preparation
Latha et al. Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration
JP2018503736A5 (cg-RX-API-DMAC7.html)
CA2340898A1 (en) Compositions and methods for treating intracellular infections
JP2002544214A5 (cg-RX-API-DMAC7.html)
CA2427899A1 (fr) Microgranules a base de principe actif et leur procede de fabrication
WO1999038496A1 (en) Fast dissolving pharmaceutical products
ATE309788T1 (de) Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung